Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CURE: intensive early rheumatoid arthritis treatment with adalimumab
2006-003843-22Phase 4Active
- Sponsor
- IRCCS San Matteo Foundation
- Start
- Aug 2006
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised trial of adalimumab in rheumatoid arthritis (RA) (2 arms), sponsored by IRCCS San Matteo Foundation. Primary endpoint: Remission at 12 months. Started Aug 2006; status: active.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2006-003843-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003843-22.